Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorMartínez-Trufero, Javier
dc.contributor.authorDe Sande-González, Luis Miguel
dc.contributor.authorLuna, Pablo
dc.contributor.authorÁlvarez, Rosa
dc.contributor.authorValverde Morales, Claudia Maria
dc.contributor.authorMartin-Broto, Javier
dc.contributor.authorMarquina, Gloria
dc.date.accessioned2021-06-01T11:26:30Z
dc.date.available2021-06-01T11:26:30Z
dc.date.issued2021-02-14
dc.identifier.citationMartínez-Trufero J, De Sande-González LM, Luna P, Martin-Broto J, Álvarez R, Marquina G, et al. A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study. Cancers. 2021 Feb 14;13(4):792.
dc.identifier.issn2072-6694
dc.identifier.urihttps://hdl.handle.net/11351/6001
dc.descriptionL-sarcoma; Índex de modulació del creixement; Sarcoma
dc.description.sponsorshipThis research was funded by the Spanish Group for Research on Sarcoma (grant number: NA) and partially by PharmaMar. PharmaMar S.A. did not have any role in study design, or in collection, analysis and interpretation of data.
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofseriesCancers;13(4)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectTumors de parts toves
dc.subjectMedicaments - Eficàcia
dc.subject.meshSoft Tissue Neoplasms
dc.subject.mesh/drug therapy
dc.subject.meshEffectiveness
dc.titleA Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3390/cancers13040792
dc.subject.decsneoplasias de los tejidos blandos
dc.subject.decs/farmacoterapia
dc.subject.decsefectividad
dc.relation.publishversionhttps://doi.org/10.3390/cancers13040792
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Martínez-Trufero J] Javier Martinez-Trufero, Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain. [De Sande-González LM] Medical Oncology Department, Complejo Asistencial Universitario de Leon, Leon, Spain. [Luna P] Medical Oncology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain. [Martin-Broto J] Medical Oncology Department, Hospital Universitario Virgen del Rocio, Instituto de Biomedicina de Sevilla (IBiS; CSIC, US, HUVR), Sevilla, Spain. [Álvarez R] Medical Oncology Department, Hospital Universitario Gregorio Marañon, Madrid, Spain. [Marquina G] Medical Oncology Department, Hospital Universitario Clinico San Carlos, Madrid, Spain. [Valverde-Morales CM] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid33672857
dc.identifier.wos000623337400001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple